A Birmingham, Alabama, tax return preparer pleaded guilty to aiding and assisting in the preparation of a false tax return, announced Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division and U.S. Attorney for the Northern District of Alabama Prim F. Escalona.
According to documents and information provided to the court, Shuntan Rue owned and operated a tax return preparation business in the Birmingham, Alabama, area known as Rue Tax Service. Between 2013 and 2016, Rue prepared and filed false tax returns for her clients by claiming education credits and itemized deductions, among other items, to which her clients were not entitled. As a result of these false tax returns, Rue caused her clients to underpay their income taxes. In addition, Rue claimed similar false items on her own 2012 and 2013 federal income tax returns. Rue conduct caused a loss to the IRS of more than $250,000.
U.S. District Senior Judge Karon O. Bowdre scheduled sentencing for Feb. 3, 2021. Rue faces a statutory maximum sentence of three years in prison. She also faces a period of supervised release, restitution, and monetary penalties.
Principal Deputy Assistant Attorney General Zuckerman and U.S. Attorney Escalona thanked special agents of IRS-Criminal Investigation, who conducted the investigation, Trial Attorneys Kevin Schneider, Jessica Kraft, and Michael Jones of the Tax Division, and Assistant U.S. Attorney Robert Posey, who are prosecuting the case.
Additional information about the Tax Division and its enforcement efforts may be found on the division’s website.
- Upholding Research Integrity at HHSBy Sam NewsFebruary 17, 2021February 17, 2021 By: [Read More…]
- Acting Assistant Attorney General Brian Rabbitt Delivers Remarks at the PPP Criminal Fraud Enforcement Action Press ConferenceBy Sam NewsSeptember 10, 2020Over the course of the past six months, the COVID-19 pandemic has wreaked havoc across our country and presented unprecedented challenges for ordinary Americans from all walks of life.[Read More…]
- Laboratory Owner Sentenced to 82 Months in Prison for COVID-19 Kickback SchemeBy Sam NewsNovember 9, 2021A Florida owner of multiple diagnostic testing laboratories was sentenced today in the Southern District of Florida to 82 months in prison for a scheme to defraud the United States and to pay and receive kickbacks through exploiting regulatory waivers put in place to ensure access to health care during the COVID-19 pandemic.[Read More…]
- Louisiana Man Pleads Guilty to Dog FightingBy Sam NewsJune 30, 2021A Louisiana man pleaded guilty yesterday to possession of an animal for use in an animal fighting venture.[Read More…]
- Quantadyn Corporation And Owner Settle False Claims Act Allegations of Bribery To Obtain Government Contracts For SimulatorsBy Sam NewsSeptember 15, 2020The Department of Justice announced today that QuantaDyn Corporation (QuantaDyn), headquartered in Ashburn, Virginia, has agreed to resolve civil claims arising from allegations that it engaged in a bribery scheme to steer government contracts for training simulators to the company, as part of a broader settlement that includes a guilty plea by the company. As part of the plea agreement, QuantaDyn has agreed to pay $37,757,713.91 in restitution, which also will resolve the company’s civil False Claims Act liability for the scheme. William T. Dunn Jr., the majority owner, President, and Chief Executive Officer of QuantaDyn, has separately paid $500,000 to resolve his personal False Claims Act liability.[Read More…]
- FDA Workforce: Agency-Wide Workforce Planning Needed to Ensure Medical Product Staff Meet Current and Future NeedsBy Sam NewsJanuary 14, 2022What GAO Found The U.S. Food and Drug Administration (FDA)—an agency of the Department of Health and Human Services (HHS)—is responsible for, among other things, ensuring the safety, efficacy, and security of human medical products marketed in the United States. FDA has used a variety of strategies to improve the agency's ability to recruit and retain the scientific, technical, and professional staff for its three centers responsible for the oversight of human medical products. These centers—the Center for Biologics Evaluation and Research, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health—were the focus of GAO's review. To improve both recruitment and retention for these centers, FDA leveraged the hiring and pay flexibilities provided by the 21st Century Cures Act (Cures Act) to expedite hiring and to offer higher salaries than the agency could under traditional federal hiring authorities. FDA has used these flexibilities to hire and retain staff such as scientists, physicians, and regulatory counsel, for whom pay disparities with the private sector are especially large. FDA also established a team dedicated to engaging with the scientific community and established a unified branding strategy that emphasizes the agency's public health mission. GAO found that FDA follows some leading practices for effective workforce planning for medical product staff. FDA's medical product centers each conduct yearly workforce planning in which they determine the skills they need and develop strategies to address identified gaps. However, FDA does not have an agency-wide strategic workforce plan to coordinate human capital efforts across the medical product centers, nor does it have performance measures in place to evaluate the effectiveness of its human capital strategies, as called for by leading practices of effective workforce planning. FDA Workforce Planning Activities for Medical Product Staff As Compared to GAO-Identified Leading Practices for Effective Workforce Planning Leading practice Alignment between FDA actions and leading practices Determine needed skills and develop strategies to address gaps ● Monitor and evaluate progress toward human capital goals ◒ Develop a strategic workforce plan ◯ Legend: ● = Aligned with leading practices; ◒ = Partially aligned with leading practices; ○ = Not aligned with leading practices Source: GAO analysis of Food and Drug Administration documents and interviews with officials. | GAO-22-104791 Further, FDA does not have a process to update such a plan on an ongoing basis should one be developed. FDA's last agency-wide strategic workforce plan—covering fiscal years 2010 through 2012—was developed under prior leadership and current agency officials were not aware of it. Without an agency-wide strategic workforce plan and a process to keep it up to date, FDA lacks reasonable assurance that actions taken within its individual centers and offices will help the agency achieve its overarching goals and mission over time. Why GAO Did This Study FDA relies on a qualified medical product workforce to achieve its mission to protect public health. However, FDA has faced challenges meeting its medical product workforce needs, due in part to competition with the private sector for candidates. Enacted in 2016, the 21st Century Cures Act provided additional flexibilities to facilitate FDA's recruitment and retention of medical product staff and included a provision for GAO to study FDA's recruitment and retention of these staff. This report: (1) describes the strategies FDA uses to recruit, hire, and retain medical product staff, and (2) evaluates the workforce planning processes FDA uses for these staff and whether these processes follow leading workforce planning practices. GAO analyzed FDA policies, guidance, reports, and data related to recruitment and retention of medical product staff and workforce planning. GAO also interviewed FDA officials responsible for hiring these staff and nonprofit and private sector organizations representing scientific staff.[Read More…]
- North Carolina Man Pleads Guilty to Promoting Nationwide Tax Fraud SchemeBy Sam NewsJanuary 4, 2022A North Carolina man pleaded guilty yesterday to conspiring to defraud the United States by promoting a nationwide tax fraud scheme and assisting in the preparation and filing of false tax returns for the scheme’s participants.[Read More…]
- Attorney General Garland Issues Statement on 2020 FBI Hate Crimes in the United States StatisticsBy Sam NewsAugust 30, 2021Attorney General Merrick B. Garland issued the following statement on the FBI’s announcement of the 2020 Hate Crimes Statistics:[Read More…]
- Man Pleads Guilty to Directing COVID-Relief Fraud SchemeBy Sam NewsFebruary 23, 2021A Wisconsin man pleaded guilty today for his role in fraudulently obtaining over $1 million in Paycheck Protection Program (PPP) loans guaranteed by the Small Business Administration (SBA) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.[Read More…]
- COVID-19: Agencies Are Taking Steps to Improve Future Use of Defense Production Act AuthoritiesBy Sam NewsDecember 16, 2021What GAO Found Federal agencies used the Defense Production Act (DPA) and other actions over 100 times to help address COVID-19 medical supply needs through September 2021. Agencies used DPA authorities to 1) prioritize contracts so those orders can get preference over others, (2) fund projects to expand domestic production of supplies, and (3) enter into partnerships with private companies (see figure). Defense Production Act and Other Actions, March 2020-September 2021 aOther actions refer to production expansion projects not executed under DPA Title III authority. Representatives from companies that received DPA awards generally stated that the use of the DPA gave them timely access to raw materials and supplies and helped them expand production faster than they could have on their own. GAO previously reported that federal agencies faced challenges using DPA authorities. Agencies have taken some steps to address these obstacles as well as one of two recommendations GAO made. The Department of Health and Human Services (HHS), which had limited DPA experience prior to COVID-19, reported establishing offices to review DPA priority rating requests and to manage industrial base expansion efforts. However, it has not developed a plan for using DPA and other actions to address future medical supply needs as GAO recommended. The Department of Defense, which has been providing significant contracting support to HHS, documented procedures to facilitate the timely transfer of funds between the two agencies and established a permanent office in October 2020 to support interagency needs. The Office of Management and Budget established a web page to collect and publish data on DPA priority ratings, which addressed a prior GAO recommendation concerning transparent reporting of these DPA actions. Additional DPA and other actions are expected through 2025 as agencies use $10 billion appropriated in the American Rescue Plan Act for medical supply investments and implement a September 2021 national strategy to strengthen the domestic medical industrial base. GAO plans to monitor agencies' efforts. Why GAO Did This Study COVID-19 put the U.S. health care system under severe strain, affecting federal agencies' ability to buy and maintain critical medical supplies to help treat patients and protect health care workers. The federal government's COVID-19 response included a significant use of DPA authorities, as well as other actions focused on expanding domestic production of medical supplies to help stabilize the medical supply chain. The CARES Act and other supplemental appropriations provided at least $11 billion for DPA purchases and other actions related to COVID-19 or other public health emergencies through September 2025. The CARES Act includes a provision for GAO to monitor funds provided for the COVID-19 pandemic. This report summarizes federal agencies' use of the DPA to respond to COVID-19 and industry perspectives, as well as implementation challenges and steps agencies have taken to address these challenges. This report summarizes information contained in reports issued in June, September, and November 2020, and January, March, April and July 2021, and provides data updates through September 2021.[Read More…]
- Special Envoy Malley’s Trip to the Middle East By Sam NewsOctober 13, 2021Office of the [Read More…]
- Former NGO Procurement Official Sentenced to Prison for BriberyBy Sam NewsMay 24, 2021A former non-governmental organization (NGO) official was sentenced today to 40 months in prison for paying bribes to NGO officers in exchange for sensitive procurement information related to NGO contracts funded in part by the U.S. Agency for International Development (USAID).[Read More…]
- DOD Civilian Personnel: Greater Oversight and Quality Assurance Needed to Ensure Force Health Protection and Surveillance for Those DeployedBy Sam NewsAugust 31, 2021As the Department of Defense (DOD) has expanded its involvement in overseas military operations, it has grown increasingly reliant on its federal civilian workforce to support contingency operations. The Senate Armed Services Committee required GAO to examine DOD's policies concerning the health care for DOD civilians who deploy in support of contingency operations in Afghanistan and Iraq. GAO analyzed over 3,400 deployment-related records for deployed federal civilians and interviewed department officials to determine the extent to which DOD has established and the military services and defense agencies (hereafter referred to as DOD components) have implemented (1) force health protection and surveillance policies and (2) medical treatment policies and procedures for its deployed federal civilians. GAO also examined the differences in special pays and benefits provided to DOD's deployed federal civilians and military personnel.DOD has established force health protection and surveillance policies to assess and reduce or prevent health risks for its deployed federal civilian personnel, but it lacks procedures to ensure implementation. Our review of over 3,400 deployment records at eight component locations found that components lacked documentation that some federal civilian personnel who deployed to Afghanistan and Iraq had received, among other things, required pre- and post-deployment health assessments and immunizations. These deficiencies were most prevalent at Air Force and Navy locations, and one Army location. As a larger issue, DOD lacked complete and centralized data to readily identify its deployed federal civilians and their movement in theater, further hindering its efforts to assess the overall effectiveness of its force health protection and surveillance capabilities. In August 2006, DOD issued a revised policy which outlined procedures that are intended to address these shortcomings. However, these procedures are not comprehensive enough to ensure that DOD will know the extent to which its components are complying with existing health protection requirements. In particular, the procedures do not establish an oversight and quality assurance mechanism for assessing the implementation of its force health protection and surveillance requirements. Until DOD establishes a mechanism to strengthen its force health protection and surveillance oversight, it will not be effectively positioned to ensure compliance with its policies, or the health care and protection of deployed federal civilians. DOD has also established medical treatment policies for its deployed federal civilians which provide those who require treatment for injuries or diseases sustained during overseas hostilities with care that is equivalent in scope to that provided to active duty military personnel under the DOD military health system. GAO reviewed a sample of seven workers' compensation claims (out of a universe of 83) filed under the Federal Employees' Compensation Act by DOD federal civilians who deployed to Iraq. GAO found in three cases where care was initiated in theater, that the affected civilians had received treatment in accordance with DOD's policies. In all seven cases, DOD federal civilians who requested care after returning to the United States had, in accordance with DOD's policies, received medical examinations and/or treatment for their deployment-related injuries or diseases through either military or civilian treatment facilities. DOD provides certain special pays and benefits to its deployed federal civilians, which generally differ in type and/or amount from those provided to deployed military personnel. For example, both civilian and military personnel are eligible to receive disability benefits for deployment-related injuries; however, the type and amount of these benefits vary, and some are unique to each group. Further, while the survivors of deceased federal civilian and military personnel generally receive similar types of cash survivor benefits, the comparative amounts of these benefits differ.[Read More…]
- Veterans Community Care Program: Improvements Needed to Help Ensure Timely Access to CareBy Sam NewsSeptember 30, 2020In a September 2020 report, GAO found that the Department of Veterans Affairs (VA) established an appointment scheduling process for its new Veterans Community Care Program (VCCP) but did not specify allowable wait times for some key steps in the process. Further, GAO found that VA had not established an overall wait-time performance measure—that is, the maximum amount of time it should take for veterans to receive care from community providers. In 2013, GAO recommended that VA establish a wait-time measure under a prior VA community care program, and in 2018 again recommended that VA establish an achievable wait-time goal to receive care under the VCCP. VA has not implemented these recommendations. Potential Allowable Wait Time to Obtain Care through the Veterans Community Care Program Note: This figure illustrates potential allowable wait times in calendar days for eligible veterans who are referred to the Veterans Community Care Program through routine referrals (not urgent), and have VA medical center staff—Referral Coordination Team (RCT) and community care staff (CC staff)—schedule the appointments on their behalf. Given VA's lack of action over the prior 7 years in implementing wait-time measures for various community care programs, GAO believes that Congressional action is warranted requiring VA to establish such an overall measure for the VCCP. This should help to achieve timely health care for veterans. GAO found additional VCCP challenges needing VA action: (1) VA uses metrics that are remnants from the previous community care program and inconsistent with the time frames established in the VCCP scheduling process. (2) Few community providers have signed up to use the software VA intends for VA medical center (VAMC) staff and community providers to use to electronically share referral information with each other. (3) Select VAMCs faced challenges scheduling appointments in a timely manner and most did not have the full amount of community care staff VA's staffing tool recommended. In June 2019, VA implemented its new community care program, the VCCP, as required by the VA MISSION Act of 2018. This new program replaced or consolidated prior community care programs. Under the VCCP, VAMC staff are responsible for community care appointment scheduling. This statement summarizes GAO's September 2020 report. It describes for the VCCP: (1) the appointment scheduling process that VA established for veterans, (2) the metrics VA used to monitor the timeliness of appointment scheduling, (3) VA's efforts to prepare VAMC staff for appointment scheduling, and (4) VA's efforts to determine VAMC staffing needs. In performing that work, GAO reviewed VA documentation, such as guidance, referral timeliness data, and VAMC community care staffing data; conducted site visits to five VAMCs; and interviewed VA and VAMC officials. In its September 2020 report, GAO recommended that Congress consider requiring VA to establish an overall wait-time measure for the VCCP. GAO also made three recommendations to VA, including that it align its monitoring metrics with the VCCP appointment scheduling process. VA did not concur with this recommendation, but concurred with the other two. GAO maintains that all recommendations are warranted. For more information, contact Sharon M. Silas at (202) 512-7114 or email@example.com.[Read More…]
- Firestone Polymers Agrees to Settle Multiple Environmental Claims at its Louisiana Rubber Manufacturing PlantBy Sam NewsSeptember 30, 2021Firestone Polymers LLC (Firestone) has agreed to resolve alleged violations of the Clean Air Act and several other federal and state environmental laws at the company’s synthetic rubber manufacturing facility in Sulfur, Louisiana. The company will also pay a total of $3.35 million in civil penalties.[Read More…]
- Department Press Briefing – September 15, 2021By Sam NewsSeptember 15, 2021Ned Price, Department [Read More…]
- North Carolina Man Sentenced to 36 Months in Federal Prison for Preparing False Tax ReturnsBy Sam NewsDecember 23, 2020Gene Hersholt Williamson II, was sentenced yesterday to 36 months in prison for aiding and assisting in the preparation of a false tax return and ordered to pay $637,000 in restitution, announced Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division.[Read More…]
- The Impact of the Pandemic on Pregnancy: A Research ResponseBy Sam NewsJuly 29, 2020Maternal health and [Read More…]
- Remarks at UNA-USA Global Engagement SummitBy Sam NewsFebruary 22, 2021John Kerry, Special [Read More…]
- Disqualification of Pan-Democratic Lawmakers in Hong KongBy Sam NewsNovember 12, 2020Michael R. Pompeo, [Read More…]